{"id":"seebri","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL1201335","moleculeType":"Small molecule","molecularWeight":"318.44"},"aliases":["LAMA"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:07:16.760Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07489911","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)","status":"RECRUITING","sponsor":"Chiesi Slovenija, d.o.o.","startDate":"2024-11-04","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":200},{"nctId":"NCT06712563","phase":"","title":"Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-04-17","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":2000},{"nctId":"NCT05116930","phase":"PHASE2","title":"Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-19","conditions":"Post-Dural Puncture Headache","enrollment":18},{"nctId":"NCT06786767","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting","status":"COMPLETED","sponsor":"Chiesi Bulgaria","startDate":"2025-02-01","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":281},{"nctId":"NCT06531798","phase":"PHASE4","title":"Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-19","conditions":"Moderate to Severe COPD","enrollment":150},{"nctId":"NCT05862545","phase":"","title":"Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-06-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":250},{"nctId":"NCT07069829","phase":"","title":"Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-15","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1400},{"nctId":"NCT06067828","phase":"PHASE3","title":"A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-10-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":171},{"nctId":"NCT05222529","phase":"PHASE2","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-29","conditions":"Asthma","enrollment":42},{"nctId":"NCT07016412","phase":"PHASE2","title":"A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD","status":"RECRUITING","sponsor":"Verona Pharma plc","startDate":"2025-07-31","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":480},{"nctId":"NCT07282886","phase":"PHASE2","title":"VENTURI (VENTilation Using Respiratory Imaging)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-15","conditions":"Asthma","enrollment":20},{"nctId":"NCT06545500","phase":"PHASE2","title":"A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2024-08-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":46},{"nctId":"NCT04320342","phase":"PHASE3","title":"A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-04-28","conditions":"COPD, COPD Exacerbation","enrollment":3433},{"nctId":"NCT06948409","phase":"","title":"NMBA Reversal and Postoperative Urinary Retention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-06-08","conditions":"Neuromuscular Blocking Agents, Urinary Retention After Procedure, Urinary Retention Postoperative","enrollment":70000},{"nctId":"NCT06112353","phase":"PHASE4","title":"Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-04-17","conditions":"Intestinal Disease","enrollment":128},{"nctId":"NCT07340008","phase":"NA","title":"Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-09-01","conditions":"Orofacial Clefts, Cleft Lip and Palate, Alveolar Ridge Defect","enrollment":60},{"nctId":"NCT07132983","phase":"PHASE2","title":"A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2025-10-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":33},{"nctId":"NCT06368427","phase":"","title":"Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-04-30","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":10},{"nctId":"NCT06110403","phase":"PHASE1, PHASE2","title":"Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2023-09-29","conditions":"Copd","enrollment":35},{"nctId":"NCT07273851","phase":"NA","title":"Comparison of Propofol and Ketofol as Induction Agents for Electroconvulsive Therapy","status":"COMPLETED","sponsor":"Fauji Foundation Hospital","startDate":"2025-07-01","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT05985343","phase":"PHASE4","title":"The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction","status":"COMPLETED","sponsor":"Clayton Petro","startDate":"2024-01-15","conditions":"Hernia, Ventral, Ileus","enrollment":184},{"nctId":"NCT03081156","phase":"PHASE4","title":"The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD","status":"COMPLETED","sponsor":"William Stringer, md","startDate":"2017-03-27","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":52},{"nctId":"NCT05256901","phase":"PHASE4","title":"Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy","status":"TERMINATED","sponsor":"Emory University","startDate":"2023-07-19","conditions":"Appendicitis, Surgery","enrollment":22},{"nctId":"NCT02129660","phase":"PHASE2","title":"Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2014-04","conditions":"Hyperhidrosis","enrollment":105},{"nctId":"NCT04027972","phase":"EARLY_PHASE1","title":"Pharmacokinetics of Neostigmine and Glycopyrrolate","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2020-03-09","conditions":"Spinal Cord Injuries, Constipation, Fecal Incontinence","enrollment":13},{"nctId":"NCT06351852","phase":"EARLY_PHASE1","title":"Transdermal Administration by a Novel Wireless Iontophoresis Device","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2022-03-22","conditions":"Spinal Cord Injuries, Constipation, Fecal Incontinence","enrollment":2},{"nctId":"NCT06398899","phase":"NA","title":"Sugammadex v.s. Neostigmine/Glycopyrrolate","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2024-05-01","conditions":"Head and Neck Surgery, Chronic Sinusitis, Chronic Otitis Media","enrollment":124},{"nctId":"NCT05887375","phase":"PHASE4","title":"Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Missouri-Columbia","startDate":"2023-08-03","conditions":"Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative","enrollment":118},{"nctId":"NCT06075095","phase":"PHASE3","title":"A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-01-11","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":297},{"nctId":"NCT06744374","phase":"","title":"A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-02-29","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":22369},{"nctId":"NCT06228092","phase":"PHASE4","title":"Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients","status":"COMPLETED","sponsor":"Matias Vested","startDate":"2023-12-04","conditions":"Neuromuscular Blockade, Residual","enrollment":40},{"nctId":"NCT06282861","phase":"PHASE4","title":"ANTES B+ Clinical Trial","status":"TERMINATED","sponsor":"Fundacio Privada Mon Clinic Barcelona","startDate":"2024-02-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":48},{"nctId":"NCT06841640","phase":"PHASE1, PHASE2","title":"Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD","status":"COMPLETED","sponsor":"AeroRx Therapeutics Inc.","startDate":"2025-01-15","conditions":"COPD","enrollment":24},{"nctId":"NCT03909165","phase":"PHASE4","title":"Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-07-23","conditions":"Neuromuscular Blockade","enrollment":145},{"nctId":"NCT03111121","phase":"PHASE4","title":"Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2017-05-04","conditions":"Microlaryngoscopy, Rigid Bronchoscopy","enrollment":79},{"nctId":"NCT06962007","phase":"NA","title":"Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal","status":"COMPLETED","sponsor":"Wonkwang University Hospital","startDate":"2025-05-01","conditions":"Neuromuscular Blockade Reversal Agent, Perioperative Complications, Anesthesia, General","enrollment":240},{"nctId":"NCT03116997","phase":"PHASE3","title":"Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-04-07","conditions":"Surgery","enrollment":201},{"nctId":"NCT04937543","phase":"PHASE2","title":"Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19","status":"COMPLETED","sponsor":"UPECLIN HC FM Botucatu Unesp","startDate":"2021-06-28","conditions":"Covid19","enrollment":50},{"nctId":"NCT03679611","phase":"PHASE4","title":"Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2019-01-14","conditions":"Obstructive Sleep Apnea","enrollment":120},{"nctId":"NCT05664633","phase":"PHASE1, PHASE2","title":"The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures","status":"WITHDRAWN","sponsor":"West Virginia University","startDate":"2023-08","conditions":"Postoperative Urinary Retention","enrollment":""},{"nctId":"NCT06844175","phase":"","title":"Early Screening of Young COPD and Pre-COPD","status":"NOT_YET_RECRUITING","sponsor":"yanmengkang","startDate":"2025-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":100},{"nctId":"NCT06234345","phase":"PHASE3","title":"Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1252},{"nctId":"NCT05545280","phase":"PHASE4","title":"Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2023-12-01","conditions":"Neuromuscular Blockade","enrollment":50},{"nctId":"NCT04159610","phase":"PHASE2","title":"Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis","status":"WITHDRAWN","sponsor":"Dr. August Wolff GmbH & Co. KG Arzneimittel","startDate":"2019-12","conditions":"Primary Axillary Hyperhidrosis","enrollment":""},{"nctId":"NCT06745492","phase":"","title":"Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2022-10-01","conditions":"Recovery Time","enrollment":59},{"nctId":"NCT06735443","phase":"PHASE2, PHASE3","title":"Comparative Efficacy & Safety of Dexmedetomidine vs Tramadol in Paeds Hernioraphy. A Caudal Anaesthesia Approach","status":"COMPLETED","sponsor":"Sahiwal medical college sahiwal","startDate":"2021-03-06","conditions":"Hemodynamic Stability, Post Operative Pain, Inguinal Hernia Repair","enrollment":60},{"nctId":"NCT06514144","phase":"","title":"Exacerbations Among Patients Receiving Breztri (EROS Study)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-10-01","conditions":"Pulmonary Disease, Chronic Obstructive, Retrospective Studies","enrollment":2409},{"nctId":"NCT06678191","phase":"","title":"Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting","status":"RECRUITING","sponsor":"Chiesi Hungary Ltd.","startDate":"2024-10-24","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale","enrollment":800},{"nctId":"NCT06053541","phase":"","title":"Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-04-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":3015000},{"nctId":"NCT06045364","phase":"PHASE1, PHASE2","title":"Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation","status":"COMPLETED","sponsor":"Jie Chen","startDate":"2023-10-01","conditions":"Nausea and Vomiting","enrollment":130},{"nctId":"NCT05830071","phase":"PHASE1","title":"A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-03-29","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD)","enrollment":95},{"nctId":"NCT05331651","phase":"PHASE4","title":"Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-04-21","conditions":"Postoperative Nausea and Vomiting","enrollment":480},{"nctId":"NCT04536402","phase":"","title":"Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-03-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":3520},{"nctId":"NCT04546672","phase":"PHASE4","title":"Sugammadex To IMprove Bowel Function","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2021-03-16","conditions":"Bowel Dysfunction, Postoperative Complications, Neuromuscular Blockade","enrollment":120},{"nctId":"NCT05993390","phase":"NA","title":"Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-01-11","conditions":"Neuromuscular Blockade, Critical Illness, Neurologic Findings","enrollment":30},{"nctId":"NCT06376942","phase":"PHASE2, PHASE3","title":"A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-04-24","conditions":"Subjects Undergoing Flexible Bronchoscopy","enrollment":1050},{"nctId":"NCT06351995","phase":"PHASE3","title":"Neostigmine and Glycopyrrolate by Iontophoresis","status":"ACTIVE_NOT_RECRUITING","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2020-11-06","conditions":"Spinal Cord Injuries, Constipation, Fecal Incontinence","enrollment":6},{"nctId":"NCT05863104","phase":"PHASE2","title":"Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis","status":"COMPLETED","sponsor":"Dr. August Wolff GmbH & Co. KG Arzneimittel","startDate":"2023-03-07","conditions":"Primary Axillary Hyperhidrosis","enrollment":44},{"nctId":"NCT06317428","phase":"","title":"NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.","status":"RECRUITING","sponsor":"Istituto Nazionale di Ricovero e Cura per Anziani","startDate":"2022-06-28","conditions":"COPD","enrollment":29},{"nctId":"NCT04606901","phase":"PHASE4","title":"Comparison of Time to Extubation Using Sugammadex or Neostigmine","status":"COMPLETED","sponsor":"Temple University","startDate":"2021-04-08","conditions":"Neuromuscular Blockade, Chronic Obstructive Pulmonary Disease","enrollment":58},{"nctId":"NCT05948891","phase":"","title":"Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study","status":"RECRUITING","sponsor":"Chiesi SAS","startDate":"2023-08-01","conditions":"COPD","enrollment":500},{"nctId":"NCT05718934","phase":"PHASE4","title":"Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2022-11-08","conditions":"Neuromuscular Blockade","enrollment":144},{"nctId":"NCT06237478","phase":"NA","title":"Effects of Glycopyrrolate on Heart Rate and Heart Rate Variability in Patients With Different Basic Heart Rate","status":"COMPLETED","sponsor":"Zhuan Zhang","startDate":"2023-03-01","conditions":"Glycopyrrolate","enrollment":54},{"nctId":"NCT05970263","phase":"PHASE4","title":"IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2024-01-19","conditions":"COPD","enrollment":""},{"nctId":"NCT05693246","phase":"NA","title":"Effect of Perioperative Use of Glycopyrrolate on Lung Function in Patients Under General Anesthesia","status":"UNKNOWN","sponsor":"Zhuan Zhang","startDate":"2022-10-01","conditions":"Glycopyrrolate","enrollment":90},{"nctId":"NCT02100280","phase":"PHASE4","title":"The Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-06-29","conditions":"Neuromuscular Blockade","enrollment":96},{"nctId":"NCT03939923","phase":"PHASE4","title":"Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2019-05-01","conditions":"Surgery, Coronary Artery Disease","enrollment":84},{"nctId":"NCT06041984","phase":"PHASE1, PHASE2","title":"Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy","status":"UNKNOWN","sponsor":"Jie Chen","startDate":"2023-10-08","conditions":"Glycopyrrolate, Colonoscopy","enrollment":150},{"nctId":"NCT04022733","phase":"NA","title":"Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2019-10-30","conditions":"Hernia Abdominal Wall","enrollment":134},{"nctId":"NCT03904550","phase":"PHASE2","title":"Neuromuscular Blockade in Patients With Severe Renal Impairment","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-12-10","conditions":"Neuromuscular Blockade, Renal Impairment","enrollment":49},{"nctId":"NCT03742141","phase":"NA","title":"Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-10-17","conditions":"Vocal Cord Function in Neck Procedures","enrollment":125},{"nctId":"NCT03513406","phase":"PHASE3","title":"Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-03-15","conditions":"Burns","enrollment":7},{"nctId":"NCT05997004","phase":"NA","title":"Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"National Academy of Medical Sciences, Nepal","startDate":"2018-05-01","conditions":"Bradyarrhythmia, Cardiac Arrest, Tachycardia","enrollment":62},{"nctId":"NCT03915821","phase":"NA","title":"Memory Changes in Patients With Major Depression Disorder Treated With ECT","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-12-15","conditions":"Depressive Disorder","enrollment":60},{"nctId":"NCT03735563","phase":"PHASE4","title":"Premedication for Less Invasive Surfactant Administration","status":"RECRUITING","sponsor":"University of Oulu","startDate":"2019-02-11","conditions":"Surfactant Deficiency Syndrome Neonatal","enrollment":40},{"nctId":"NCT05099055","phase":"PHASE3","title":"Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study","status":"COMPLETED","sponsor":"St. Justine's Hospital","startDate":"2022-03-15","conditions":"Analgesia, Analgesics, Opioid, Anesthesia, Obstetrical","enrollment":42},{"nctId":"NCT02867761","phase":"PHASE3","title":"RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2017-08-29","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":780},{"nctId":"NCT02825576","phase":"PHASE4","title":"Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine","status":"TERMINATED","sponsor":"Northern Sydney Anaesthesia Research Institute","startDate":"2018-12-03","conditions":"Pulmonary Complications","enrollment":30},{"nctId":"NCT05265507","phase":"PHASE4","title":"Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-03-21","conditions":"Postoperative Nausea and Vomiting","enrollment":480},{"nctId":"NCT03290287","phase":"","title":"Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":26839},{"nctId":"NCT05694234","phase":"","title":"Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2021-09-01","conditions":"Myasthenia Gravis","enrollment":265},{"nctId":"NCT01845441","phase":"PHASE2","title":"Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2012-04","conditions":"Stroke, Brain Ischemia, Vasospasm, Intracranial","enrollment":7},{"nctId":"NCT05253404","phase":"NA","title":"Laryngeal Mask Airway Facilitates a Safe and Smooth Emergence From Anesthesia in Patients Undergoing Craniotomy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-02-15","conditions":"Complications, Pulmonary","enrollment":62},{"nctId":"NCT05288075","phase":"PHASE1","title":"Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2022-02-28","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT03112993","phase":"PHASE4","title":"Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2017-05-30","conditions":"Spine Surgery","enrollment":40},{"nctId":"NCT01937247","phase":"PHASE2, PHASE3","title":"Redesigned Process in the Operating Room","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2018-05-18","conditions":"Non-operative Time, General Surgery, Above 18 Years of Age","enrollment":120},{"nctId":"NCT04873531","phase":"NA","title":"Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-05-10","conditions":"Thyroid Diseases, Surgical Injury, Nerve Monitoring","enrollment":44},{"nctId":"NCT03574337","phase":"PHASE4","title":"Residual Neuromuscular Blockade in Cardiac Surgery Patients","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2018-08-01","conditions":"Residual Neuromuscular Blockade","enrollment":""},{"nctId":"NCT04671355","phase":"PHASE4","title":"TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD","status":"WITHDRAWN","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-10-04","conditions":"COPD","enrollment":""},{"nctId":"NCT04671030","phase":"PHASE1","title":"Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2018-01-15","conditions":"Spinal Cord Injuries, Constipation, Neurogenic Bowel","enrollment":6},{"nctId":"NCT03627858","phase":"","title":"Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting","status":"COMPLETED","sponsor":"Chiesi SA/NV","startDate":"2018-08-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":149},{"nctId":"NCT03322657","phase":"PHASE4","title":"Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-11-14","conditions":"Neuromuscular Blockade, Anesthesia","enrollment":69},{"nctId":"NCT02119234","phase":"PHASE1","title":"Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-03","conditions":"COPD","enrollment":36},{"nctId":"NCT01176903","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2010-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":65},{"nctId":"NCT01176851","phase":"PHASE1","title":"Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2010-07","conditions":"Healthy","enrollment":20},{"nctId":"NCT01917331","phase":"PHASE3","title":"Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-03","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1368},{"nctId":"NCT02189577","phase":"PHASE2","title":"Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":100},{"nctId":"NCT01911364","phase":"PHASE3","title":"Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":3686},{"nctId":"NCT02040597","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":42},{"nctId":"NCT01398111","phase":"PHASE1","title":"Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2011-05","conditions":"COPD","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":28,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Seebri","genericName":"Seebri","companyName":"Fundacio Privada Mon Clinic Barcelona","companyId":"fundacio-privada-mon-clinic-barcelona","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}